// App-Quantinova.ai

: Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?

Researchers

Presenter

  • Helen Morris

Principal Investigators

  • Tracey Marshall

  • Katie Zakis

  • Theresa Garfoot

  • Conal Hayton

  • Pilar Rivera Ortega

  • Colm Leonard

  • John Blaikley

  • Nazia Chaudhuri

Medical Centers

  • NHS, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pirfenidone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved